- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New TomTec rises from ashes
TomTec's 3-D ultrasound technology lives on. The defunct ultrasound developer has sold rights to the technology to a group of managers from the company's German subsidiary in Munich. The executives have formed a new company, TomTec GmbH, with the
TomTec's 3-D ultrasound technology lives on. The defunct ultrasound developer has sold rights to the technology to a group of managers from the company's German subsidiary in Munich. The executives have formed a new company, TomTec GmbH, with the intention of carrying forward TomTec's 3-D legacy.
TomTec Imaging Systems closed its doors last month after its venture-capital backers pulled out of the company and its management failed to find new funding (SCAN 6/11/97). In liquidating the company, TomTec's management said it intended to sell off the company's assets.
The Munich-based management team includes Bernhard Mumm, Frank Schlau, and Ulrich Haupt, who intend to resume on a worldwide basis all of the 3-D business activities and end-user relationships of TomTec Imaging Systems. The Munich facility had been the headquarters of TomTec predecessor Tomographic Technologies, which was merged with Prism Imaging/Freeland Systems to create TomTec Imaging Systems in late 1993.
All of TomTec's 3-D products, including TomTec Echo-Scan, EchoView, and Compact 3-D, will continue to be produced and marketed. TomTec GmbH will also continue the development of Windows NT-based clinical procedure and visualization packages for cardiac and general imaging applications.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
